Close Menu

Back to the Bench

Harvard University's provost, Steven Hyman, is stepping down at the end of the academic year to return to research, reports The Boston Globe. Hyman is a trained neuroscientist and he plans to take a sabbatical year at the Broad Institute, which the Globe notes, was one of Hyman's efforts to spur interdisciplinary research. "I had intended to do this [job] for five years ...

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.